2023
DOI: 10.1016/j.micromeso.2023.112656
|View full text |Cite
|
Sign up to set email alerts
|

Screening of α-glucosidase inhibitors in tea by amino-functionalized mesoporous SBA-15 immobilized α-glucosidase microreactor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 41 publications
0
3
0
Order By: Relevance
“…In addition, the spectra of SBA and EXSBA show the highest intensity at 1061 cm -1 , indicating stretching vibrations of the Si-O bonds of the siloxanes that can overlap in nearby bands 39,40 . The spectra of SBA-15 before (SBA) and after loading (EXSBA) showed the characteristic bond bands of the spectra found in the literature for SBA-15 29,33,41 .…”
Section: Chemical Characterizationmentioning
confidence: 60%
“…In addition, the spectra of SBA and EXSBA show the highest intensity at 1061 cm -1 , indicating stretching vibrations of the Si-O bonds of the siloxanes that can overlap in nearby bands 39,40 . The spectra of SBA-15 before (SBA) and after loading (EXSBA) showed the characteristic bond bands of the spectra found in the literature for SBA-15 29,33,41 .…”
Section: Chemical Characterizationmentioning
confidence: 60%
“…The small-angle XRD diffraction was mainly used to characterize the mesoporous structure of SBA-15 and its derivatives as shown in the vignette of Figure 1b. The distinctive diffraction peaks were associated with SBA-15, specifically those at 0.89 , 1.55 , and 1.79 corresponding to the (100), (110), and (200) planes, 29 which exhibited a gradual reduction in intensity as the modification progressed, eventually reaching near extinction. This was mainly caused by the fact that Zn-ATMP and DOPO were immobilized in pore channels and on the surface of SBA-15.…”
Section: Characterizationmentioning
confidence: 99%
“…Diabetes is a chronic metabolic disorder characterized by inadequate production or response to insulin, resulting in elevated glucose levels in the bloodstream. α-Glucosidase inhibitors have been extensively used in the treatment of patients with type II diabetes mellitus due to their ability to slow down carbohydrate digestion and absorption [5], resulting in reduced blood glucose concentration and controlled postprandial blood glucose levels in diabetic patients [6,7]. However, the current medications available on the market for dia-betes treatment, such as acarbose, miglitol, and voglibose, often elicit gastrointestinal side effects [8,9].…”
Section: Introductionmentioning
confidence: 99%